InvestLog
Back to Market返回行情

200230.KQ TELCON RF PHARMACEUTICAL. Inc.

KOETechnology
₩360-0.28%LatestMarket Cap: ₩5.35B

As of 2026-06-02 18:00

Why 200230.KQ matters now

TELCON RF PHARMACEUTICAL. Inc. (200230.KQ) is a Korea stock in Technology. The latest InvestLog snapshot shows ₩360.00 with -0.28% on the session and ₩5.35B in market capitalization.

Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E -2.97, gross margin 16.2%, and operating margin 1.9%.

InvestLog's latest related AI research is a Stock Split note titled "200230.KQ announces 1-for-10 reverse split for 2026-06-04".

Valuation

View Details

P/E (TTM)

-2.97

PEG

—

P/B

0.25

P/S

0.12

EV/EBITDA

2.70

DCF Value

—

FCF Yield

7.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

16.2%

Operating Margin

1.9%

Net Margin

-19.4%

ROE

-8.9%

ROA

-5.5%

ROIC

0.6%

Related AI Research

Stock SplitJun 4, 2026

200230.KQ announces 1-for-10 reverse split for 2026-06-04TELCON RF PHARMACEUTICAL. Inc.（200230.KQ）宣布 1:10 合股，生效日 2026-06-04

TELCON RF PHARMACEUTICAL. Inc. (ticker: 200230.KQ) completed a 1-for-10 reverse stock split on June 4, 2026, consolidating every 10 outstanding common shares into one single share.200230.KQ对应的TELCON RF PHARMACEUTICAL. Inc.于2026年6月4日实施了1:10的反向股票拆分，每10股现有流通股将合并为1股。这一公开资本结构调整仅影响股份数量与每股报价，不直接改变公司内在价值，是市场参与者需跟踪的公司行动。

Listing Info

Market

Korea

Exchange

KOE

Currency

KRW

Sector

Technology

Industry

Communication Equipment

Country

KR

TELCON RF PHARMACEUTICAL. Inc. develops, produces, and sells RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is based in Yongin-si, South Korea.